Loading…
Pelthos Therapeutics Inc. is projected to rise to $30.05 by 2027, a +9% move from its current price of $27.57. PTHS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $26.53 | $27.58 | $28.66 | +0.03% |
| Jul 14 | $26.12 | $27.58 | $29.13 | +0.05% |
| Jul 15 | $25.81 | $27.59 | $29.50 | +0.08% |
| Jul 16 | $25.55 | $27.60 | $29.82 | +0.11% |
| Jul 17 | $25.32 | $27.61 | $30.10 | +0.13% |
| Jul 18 | $25.12 | $27.61 | $30.36 | +0.16% |
| Jul 19 | $24.94 | $27.62 | $30.59 | +0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.94 | $27.62 | $30.59 | +0.19% |
| Week 2 | $23.95 | $27.67 | $31.98 | +0.37% |
| Week 3 | $23.22 | $27.72 | $33.09 | +0.56% |
| Week 4 | $22.64 | $27.77 | $34.08 | +0.74% |
| Week 5 | $22.14 | $27.83 | $34.97 | +0.93% |
| Week 6 | $21.70 | $27.88 | $35.81 | +1.12% |
| Week 7 | $21.31 | $27.93 | $36.60 | +1.30% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pelthos Therapeutics Inc. is a bio-pharmaceutical company that develops and commercializes therapeutic products to help patients with unmet treatment burdens.
The company offers ZELSUVMI for molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform.
The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Pelthos Therapeutics Inc. (PTHS) is a healthcare stock with a current price of $28.00 and a market capitalization of $97.32M. It is ranked 4218.
The stock sits in the healthcare sector and presents a small-cap profile by market capitalization.
Near-term, the 2026 forecast shows an average price of $28.00 with a min of $18.19 and a max of $34.83; the 2026 ROI is 0% and sentiment is NEUTRAL.
Over the longer horizon, the forecast path projects rising averages through 2030 to 2050, with 2030 average $51.93 and 2050 average $239.16, and max values up to $520.54, reflecting a bullish multi-year trajectory.
A major floor 26.0% below — a decisive break under it would weaken the trend.
The nearest floor, 11.8% below — buyers have tended to step in here.
The nearest ceiling, 7.0% above — a clean break opens room to run.
A major ceiling 15.9% above — clearing it would confirm fresh momentum.
Key PTHS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PTHS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $26.13 | Buy | $26.68 | Buy |
| MA 10 | $26.93 | Buy | $26.90 | Buy |
| MA 20 | $27.63 | Sell | $27.10 | Buy |
| MA 50 | $26.77 | Buy | $26.54 | Buy |
| MA 100 | $24.84 | Buy | $25.82 | Buy |
| MA 200 | $26.30 | Buy | $24.81 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.03 | Neutral |
| Stoch RSI (14) | 42.11 | Neutral |
| CCI (20) | -61.59 | Neutral |
| Williams %R (14) | -57.06 | Info |
| MACD (12,26,9) | -0.25 | Sell |
| ROC (12) | -10.00 | Sell |
| Bollinger %B (20,2) | 0.31 | Neutral |
| Stochastic %K (14) | 42.94 | Neutral |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | -1.02 | Sell |
| Ultimate (7,14,28) | 41.98 | Neutral |
| Momentum (10) | -2.66 | Sell |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 26.70 | Buy |
| ADX (14) | 13.32 | Neutral |
| ATR (14) | 0.96 | Info |
Near-term technical picture: bullish momentum reflected in the 30-day framework.
The 30-day range runs from $21.47 to $36.52. The current technical setup features a support level at $24.33 and a resistance level at $29.50. The moving averages show SMA50 at $26.69 and SMA200 at $26.37, with RSI(14) at 50.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.19 | $27.57 | $34.03 | 0% | Neutral | |
| $23.00 | $30.05 | $42.05 | +9% | Neutral | |
| $21.86 | $29.77 | $43.76 | +8% | Neutral | |
| $26.64 | $37.56 | $57.35 | +36% | Bullish | |
| $33.14 | $48.18 | $75.97 | +75% | Bullish | |
| $35.27 | $52.77 | $85.54 | +91% | Bullish | |
| $40.68 | $62.52 | $103.85 | +127% | Bullish | |
| $40.55 | $63.92 | $108.57 | +132% | Bullish | |
| $37.69 | $60.87 | $105.51 | +121% | Bullish | |
| $40.07 | $66.25 | $117.01 | +140% | Bullish | |
| $63.62 | $117.35 | $224.05 | +326% | Bullish | |
| $93.31 | $207.35 | $442.56 | +652% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $18.19 | $27.57 | $32.90 | +0.00% |
| August 2026 | $22.77 | $27.19 | $33.56 | -1.38% |
| September 2026 | $23.42 | $28.24 | $35.39 | +3.87% |
| October 2026 | $23.08 | $28.08 | $35.64 | -0.59% |
| November 2026 | $21.66 | $26.54 | $34.05 | -5.47% |
| December 2026 | $21.29 | $26.26 | $34.03 | -1.05% |
Click any year to see its month-by-month PTHS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PTHS is projected to trade between $18.19 and $34.03, averaging $27.57 — a potential gain of 0% from today's $27.57. Price action looks broadly range-bound.
Pelthos Therapeutics Inc.'s 2027 outlook centres on $30.05, within a $23.00 to $42.05 range. That is up +9% on the projected 2026 average. That marks a +9% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, PTHS could reach as high as $43.76, with a base case around $29.77 and support toward $21.86 — roughly +8% from $27.57. Price action looks broadly range-bound.
Expect PTHS to range from $26.64 to $57.35 through 2029. The $37.56 average target implies a +36% move from current prices. That is up +26% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The PTHS price prediction for 2030 points to an average of $48.18 (low $33.14, high $75.97) — a potential gain of +75% on today's $27.57. Momentum favours further upside here.
In 2031, PTHS is projected to trade between $35.27 and $85.54, averaging $52.77 — a potential gain of +91% from today's $27.57. That is up +10% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Pelthos Therapeutics Inc.'s 2032 outlook centres on $62.52, within a $40.68 to $103.85 range. That is up +18% on the projected 2031 average. That marks a +127% change versus current levels. Momentum favours further upside here.
By 2033, PTHS could reach as high as $108.57, with a base case around $63.92 and support toward $40.55 — roughly +132% from $27.57. Buyers look set to stay in control over this stretch.
Expect PTHS to range from $37.69 to $105.51 through 2034. The $60.87 average target implies a +121% move from current prices. That is -5% versus the projected 2033 average. Momentum favours further upside here.
The PTHS price prediction for 2035 points to an average of $66.25 (low $40.07, high $117.01) — a potential gain of +140% on today's $27.57. Buyers look set to stay in control over this stretch.
In 2040, PTHS is projected to trade between $63.62 and $224.05, averaging $117.35 — a potential gain of +326% from today's $27.57. That is up +77% on the projected 2035 average. Momentum favours further upside here.
Pelthos Therapeutics Inc.'s 2050 outlook centres on $207.35, within a $93.31 to $442.56 range. That is up +77% on the projected 2040 average. That marks a +652% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in PTHS today (≈ 36.271309 PTHS) could be worth
$7,520.98
+$6,520.98 (+652%) by 2050 · US Dollar
Based on the average projected PTHS price of $207.35 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PTHSwould be worth at today's price.
$1,000 invested in PTHS on Jul 10, 2025 (≈ 37.764351 PTHS) would be worth
$1,041.16
+$41.16 (+4.1%) today · 1.04× · US Dollar
Based on a PTHS entry price of $26.48 vs. today's $27.57.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25.77 | $1,069.85 | +7.0% |
| 1 month ago | $27.42 | $1,005.47 | +0.5% |
| 3 months ago | $22.58 | $1,220.99 | +22.1% |
| 6 months ago | $25.55 | $1,079.06 | +7.9% |
| 1 year ago | $26.48 | $1,041.16 | +4.1% |
| All time (2.4y) ago | $48 | $574.38 | -42.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PTHS forecast.
Our base-case forecast reaches $55.00 around 2032.
Implied market cap at $55.00: $191.16M
The multi-year forecast portrays a bullish trajectory with rising averages across the horizon.
In 2029 the average price is $39.95 with a min of $28.06 and a max of $61.66, delivering a 42.7% ROI and bullish sentiment.
In 2030 the average price is $51.93 with a min of $35.30 and a max of $82.82, delivering an 85.5% ROI and bullish sentiment.
In 2040 the average price is $131.52 with a min of $69.43 and a max of $255.40, delivering a 369.7% ROI and bullish sentiment.
In 2050 the average price is $239.16 with a min of $107.62 and a max of $520.54, delivering a 754.1% ROI and bullish sentiment. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $51.93, with a min of $35.30 and a max of $82.82. The forecasted ROI is 85.5% and sentiment is BULLISH.
Forecasts indicate a bullish trajectory in the long term, with 2029 average $39.95 and 2050 average $239.16, and a maximum forecast of $520.54 in 2050. The ROI in 2050 is 754.1% and in earlier years is positive in several years, but these are estimates and not guarantees.
Yes. The forecasted maximums include $130.77 in 2035 and $255.40 in 2040, indicating prices could surpass $100 by 2035 or later.
The 30-day price range is $21.47 to $36.52.
Current price is $28.00 and market cap is $97.32M.
Pelthos Therapeutics Inc. Community Discussion
0Share your Pelthos Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.